Rankings
▼
Calendar
IONS FY 2021 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IONS
Ionis Pharmaceuticals, Inc.
$13B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$810M
+11.1% YoY
Gross Profit
$800M
98.7% margin
Operating Income
-$30M
-3.7% margin
Net Income
-$29M
-3.5% margin
EPS (Diluted)
$-0.20
Cash Flow
Operating Cash Flow
$31M
Free Cash Flow
$13M
Stock-Based Comp.
$121M
Balance Sheet
Total Assets
$2.6B
Total Liabilities
$1.8B
Stockholders' Equity
$772M
Cash & Equivalents
$869M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$810M
$729M
+11.1%
Gross Profit
$800M
$717M
+11.5%
Operating Income
-$30M
-$172M
+82.5%
Net Income
-$29M
-$444M
+93.6%
← Q4 2020
All Quarters
Q1 2021 →